Revolutionizing Access to Ground-Breaking Clinical Trials for Cancer Patients: Danielle Ralic, Ancora.ai


Episode Artwork
1.0x
0% played 00:00 00:00
Jan 10 2024 58 mins   1

To search for a possibly life-saving ground-breaking treatment for a cancer patient that is available only in clinical trials it takes: personal connections your oncologist network long hours frustration and luck.

Ancora.ai wants to change it.

Make clinical trials and innovative treatments more accessible for patients.

Accelerate the search for patients for clinical trial sponsors.

It takes around 5 minutes with Ancora.ai platform to search for possibly relevant clinical trials for cancer patients. But it is not the end of the story.

You’ll hear about

  • why and when to consider a clinical trial if you’re a cancer patient
  • how to find a relevant trial
  • why currently it is so frustrating for both those who run them and patients
  • how tech paired with motivated humans can help

The Founder and CEO of Ancora.ai Danielle Ralic is on a mission to bring treatments available in breakthrough clinical studies to cancer patients. She’s a technologist who used to develop analytics solutions for Pharmaceutical and Healthcare organizations. Motivated by both what she experienced professionally and in her private life while trying to search for treatments for her friends and family.

Ancora.ai is a Swiss startup that developed an AI-powered platform where cancer patients and their loved ones can search for available trials in a matter of minutes.

Here is the platform:
https://www.ancora.ai

If you've enjoyed listening, you'll make us happy by clicking "Follow" on X-Health.show and leaving a review.

The information in this podcast is for informational purposes only and should not be considered medical advice. If you have any medical questions, please consult your healthcare practitioner. The opinions on the show are Alex's or her guests. The podcast does not make any responsibility or warranties about guests statements or credibility. While the podcast makes every effort to ensure that the information shared is accurate, please let us know if you have any comments, suggestions or corrections.